Patent ID: 6303577
Filing Date: 2001-10-16
Classification: A61K,A61P

Abstract:
A method for treating a patient suffering from Systemic Lupus Erythematosus, said method comprising administering to a patient in need thereof an effective amount of a peptide compound of formula(H.sub.2 N-X.sub.1 -Thr-X.sub.2 -CO).sub.n -R (I)wherein:X.sub.1 and X.sub.2 are each an amino acid residue selected from the group consisting of tyrosine and arginine, in L or D configuration;X.sub.1 and X.sub.2 are different from each other;n is 2, 3, or 4; andR is a group able to form a dimeric, trimeric, or tetrameric peptide.